Trinity biotech obtains an extension to demonstrate compliance with nasdaq listing requirements

Dublin, aug. 06, 2024 (globe newswire) -- trinity biotech plc (nasdaq: trib), a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, obtained an extension to demonstrate compliance with a continued listing requirement of the nasdaq global select market.

TRIB Ratings Summary

TRIB Quant Ranking